JP Morgan has upgraded Aveanna Healthcare Holdings Inc (AVAH) to Neutral from Underweight, reflecting a more optimistic outlook on the company's prospects. This change in rating, effective September 17, 2025, comes as Aveanna continues to navigate the health care landscape, providing home care services to patients across the United States.
The Atlanta-based company, which employs 3,500 full-time workers, reported a current stock price of $8.53. Aveanna operates through several segments, including Private Duty Services, Home Health & Hospice, and Medical Solutions, catering to a range of patient needs. The recent upgrade suggests improved fundamentals or increased confidence in the company's strategic direction.
Analyst ratings serve as professional assessments based on extensive research and financial models. While they can offer valuable insights, it is essential for investors to consider multiple factors, including company fundamentals and industry trends, when making decisions. Analyst opinions can vary and may change as new information becomes available.
As of November 1, 2025, Aveanna holds a market capitalization of $1.7 billion, with a price-to-earnings ratio of 93.45 and earnings per share of $0.08. Upcoming earnings are expected on August 5, 2026, with an estimated EPS of $0.17 and revenue of $639.7 million. The consensus among analysts remains a Buy, with 3 Strong Buy, 6 Buy, and 6 Hold ratings recorded recently.
This update provides insight into Aveanna's evolving market position as it continues to enhance its service offerings in the health care sector.